Match tier
Listed
Presence
Formerly Arkansas
Last published
2026
Sources
OpenAlex · ORCID
Refreshed
2026-08-16
A
Ashim K. Bagchi
Researcher
Formerly Arkansas Affiliated with UAMS through 2024; recent publications list Cardiovascular Institute Hospital, University of Manitoba.
Faculty Researcher
18 h-index
67 pubs
1,290 cited
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Ashim K. Bagchi's research focuses on the molecular mechanisms underlying cardiovascular diseases, particularly those induced by chemotherapy agents like doxorubicin. His work investigates the roles of oxidative stress, endoplasmic reticulum (ER) stress, and apoptotic pathways in the development of doxorubicin-induced cardiomyopathy. Bagchi has published studies examining how factors such as Interleukin-10 and empagliflozin can mitigate these damaging effects by modulating ER stress pathways. His research also extends to other forms of heart failure, including studies on the protective effects of olive oil against cardiac remodeling following myocardial infarction in rats and the role of oxidative stress versus lipids in monocrotaline-induced pulmonary hypertension. Bagchi has a scholarly h-index of 18 with 1,290 citations across 67 publications. He has collaborated with Amanda J. Stolarz, Rushita A. Bagchi, Soumiya Pal, and Jawahar L. Mehta on multiple projects.
Metrics
- h-index: 18
- Publications: 67
- Citations: 1,290
Selected Publications
-
Obesity, histone acetylation, and insulin resistance (2024)
-
List of contributors (2024)
-
Rhythmic Contractions of Lymph Vessels and Lymph Flow Are Disrupted in Hypertensive Rats (2024)
-
Proteomics Approach to Identify Anthracycline-induced Cardiotoxicity Mechanisms in Human Cardiac Fibroblasts (2024)
-
JoVE Video Dataset (2024)
-
Real-Time Evaluation of Absolute, Cytosolic, Free Ca<sup>2+</sup> and Corresponding Contractility in Isolated, Pressurized Lymph Vessels (2024)
-
Doxorubicin‑induced cardiomyopathy is mitigated by empagliflozin via the modulation of endoplasmic reticulum stress pathways (2024)
-
The cardioprotective effects of Empagliflozin in Doxorubicin-induced endoplasmic reticulum (ER) stress (2023)
-
Lipidomic Predictors of Coronary No-Reflow (2023)
-
Olive oil protects against progression of heart failure by inhibiting remodeling of heart subsequent to myocardial infarction in rats (2022)
-
NF-κB, A Potential Therapeutic Target in Cardiovascular Diseases (2022)
-
The Structural Basis of Effective LOX-1 Inhibition (2022)
-
Interleukin-10 Mitigates Doxorubicin-Induced Endoplasmic Reticulum Stress as Well as Cardiomyopathy (2022)
Collaboration Network
Top Collaborators
Pawan K. Singal
St. Boniface Hospital (CA)
5 shared publications
- Interleukin-10 Mitigates Doxorubicin-Induced Endoplasmic Reticulum Stress as Well as Cardiomyopathy
- Olive oil protects against progression of heart failure by inhibiting remodeling of heart subsequent to myocardial infarction in rats
- Doxorubicin‑induced cardiomyopathy is mitigated by empagliflozin via the modulation of endoplasmic reticulum stress pathways
- Lipidomic Predictors of Coronary No-Reflow
- The cardioprotective effects of Empagliflozin in Doxorubicin-induced endoplasmic reticulum (ER) stress
Akshi Malik
University of Manitoba (CA)
4 shared publications
- Interleukin-10 Mitigates Doxorubicin-Induced Endoplasmic Reticulum Stress as Well as Cardiomyopathy
- Olive oil protects against progression of heart failure by inhibiting remodeling of heart subsequent to myocardial infarction in rats
- Doxorubicin‑induced cardiomyopathy is mitigated by empagliflozin via the modulation of endoplasmic reticulum stress pathways
- The cardioprotective effects of Empagliflozin in Doxorubicin-induced endoplasmic reticulum (ER) stress
Davinder S. Jassal
University of Manitoba (CA)
4 shared publications
- Interleukin-10 Mitigates Doxorubicin-Induced Endoplasmic Reticulum Stress as Well as Cardiomyopathy
- Olive oil protects against progression of heart failure by inhibiting remodeling of heart subsequent to myocardial infarction in rats
- Doxorubicin‑induced cardiomyopathy is mitigated by empagliflozin via the modulation of endoplasmic reticulum stress pathways
- The cardioprotective effects of Empagliflozin in Doxorubicin-induced endoplasmic reticulum (ER) stress
Amanda J. Stolarz
University of Arkansas for Medical Sciences
4 shared publications
In database
- Real-Time Evaluation of Absolute, Cytosolic, Free Ca<sup>2+</sup> and Corresponding Contractility in Isolated, Pressurized Lymph Vessels
- JoVE Video Dataset
- Proteomics Approach to Identify Anthracycline-induced Cardiotoxicity Mechanisms in Human Cardiac Fibroblasts
- Rhythmic Contractions of Lymph Vessels and Lymph Flow Are Disrupted in Hypertensive Rats
Soumiya Pal
University of Arkansas for Medical Sciences
3 shared publications
In database
- Real-Time Evaluation of Absolute, Cytosolic, Free Ca<sup>2+</sup> and Corresponding Contractility in Isolated, Pressurized Lymph Vessels
- JoVE Video Dataset
- Rhythmic Contractions of Lymph Vessels and Lymph Flow Are Disrupted in Hypertensive Rats
Anya Dhar
University of Michigan–Ann Arbor (US)
3 shared publications
- Proteomics Approach to Identify Anthracycline-induced Cardiotoxicity Mechanisms in Human Cardiac Fibroblasts
- List of contributors
- Obesity, histone acetylation, and insulin resistance
Rushita A. Bagchi
University of Arkansas for Medical Sciences
3 shared publications
In database
- Proteomics Approach to Identify Anthracycline-induced Cardiotoxicity Mechanisms in Human Cardiac Fibroblasts
- List of contributors
- Obesity, histone acetylation, and insulin resistance
Jawahar L. Mehta
Central Arkansas Veterans Healthcare System
2 shared publications
In database
- NF-κB, A Potential Therapeutic Target in Cardiovascular Diseases
- The Structural Basis of Effective LOX-1 Inhibition
Rajshekhar A. Kore
Central Arkansas Veterans Healthcare System
1 shared publication
In database
- The Structural Basis of Effective LOX-1 Inhibition
Kottayil I. Varughese
University of Arkansas for Medical Sciences (US)
1 shared publication
- The Structural Basis of Effective LOX-1 Inhibition
W. T. K. Cheng
Xinxiang Medical University (CN)
1 shared publication
- NF-κB, A Potential Therapeutic Target in Cardiovascular Diseases
Can Cui
First Affiliated Hospital of Xinxiang Medical University (CN)
1 shared publication
- NF-κB, A Potential Therapeutic Target in Cardiovascular Diseases
Gang Liu
Xinxiang Medical University (CN)
1 shared publication
- NF-κB, A Potential Therapeutic Target in Cardiovascular Diseases
Chenji Ye
Xinxiang Medical University (CN)
1 shared publication
- NF-κB, A Potential Therapeutic Target in Cardiovascular Diseases
Shao Fang
Zhengzhou Central Hospital (CN)
1 shared publication
- NF-κB, A Potential Therapeutic Target in Cardiovascular Diseases
Similar Researchers
Based on overlapping research topics
Kate Steed
University of Arkansas for Medical Sciences
Pharmacological Effects and Toxicity Studies
Disease Mechanisms Research
Cardiovascular Function and Risk Factors
Rupak Pathak
University of Arkansas for Medical Sciences
Pharmacological Effects and Toxicity Studies
Disease Mechanisms Research
Mitochondrial Function and Pathology
Koichiro Nagano
University of Arkansas for Medical Sciences
Pharmacological Effects and Toxicity Studies
Disease Mechanisms Research
Cardiovascular Function and Risk Factors
Nancy J. Rusch
University of Arkansas for Medical Sciences
Pharmacological Effects and Toxicity Studies
Disease Mechanisms Research
Cardiovascular Function and Risk Factors
Tong Mu
University of Arkansas – Fort Smith
Pharmacological Effects and Toxicity Studies
Disease Mechanisms Research
Cardiovascular Function and Risk Factors
Esraa Shosha
University of Arkansas for Medical Sciences
Pharmacological Effects and Toxicity Studies
Disease Mechanisms Research
Cardiovascular Function and Risk Factors